2026 Video Webinar Series

340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders

Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the editor of Drug Channels, for his latest exclusive video webinar:

340B in 2026: Market Shifts, Policy Battles,
and What They Mean for Stakeholders

This event will be broadcast live on:
Friday, June 12, 2026
12:00 p.m. to 1:30 p.m. ET

Register Now

The webinar will be broadcast live from the Drug Channels studio in beautiful downtown Philadelphia. It is part of The Drug Channels 2026 Video Webinar Series.

WHAT YOU WILL LEARN

Join industry expert Adam J. Fein, Ph.D., for an exclusive deep dive into the 340B Drug Pricing Program—one of the most complex and controversial segments of the U.S. pharmaceutical market.

In this all-new webinar, Dr. Fein will deliver a fact-based, data-driven analysis of the 340B program’s structure, economics, and rapid evolution. He’ll unpack the key controversies reshaping the program, explain what’s really happening behind the headlines, and provide a clear, actionable outlook for stakeholders across the drug channel.

Whether you’re in pharma, provider organizations, pharmacy, or policy, you’ll gain the insights needed to understand where 340B is headed—and what it means for your business.

Key topics include:

  • The structure and economics of the 340B program
  • Growth trends among covered entities and their partners
  • 340B’s expanding role in pharmacy—and its impact on PBMs and retail
  • DCI’s latest data on the contract pharmacy marketplace and the leading participants
  • The role of third-party administrators and vendors in the 340B ecosystem
  • What’s behind the growing controversy over the definition of an eligible patient
  • Why diversion and duplicate discounts have become flashpoints
  • The implications of the Net Pricing Drug Channel for 340B pricing dynamics
  • How 340B funds are generated and distributed across participating entities
  • How employers and plan sponsors could reshape the program’s future
  • Manufacturers’ evolving distribution strategies for 340B contract pharmacies
  • Recent legal developments affecting manufacturer policies and contract pharmacy arrangements
  • The expanding influence of state legislation
  • The impact of the Inflation Reduction Act on program operations and oversight
  • The HRSA vs. CMS oversight crisis
  • The outlook for a potential 340B rebate model
  • What’s ahead for state and federal policy
  • Emerging risks, challenges, and threats to watch

Plus: fresh insights and expert perspective you won’t find anywhere else.

As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data.

This 90-minute video webinar will feature a dedicated Q&A session, where attendees can unmute and engage directly with Dr. Fein.

Register now to stay informed and get ahead of the curve on 340B!

PRICING OPTIONS

Take advantage of this exclusive educational opportunity for just $420 per viewing device. Once you register, you’ll receive a unique Zoom access link within 24 hours—making it easy to add the event to your calendar and ensure you don’t miss out.

Special Discounts For Teams!

We understand that many professionals are working remotely, so we’re offering substantial savings for multiple registrations from the same organization. What’s more, an unlimited number of attendees can watch together at a single physical location with one registered device.

Important Reminder: Each device at a single physical location must have its own registration. The webinar may not be recorded, streamed, broadcast, or shared across different locations, devices, or sites.

Click here to register. All discounts will be automatically computed based on the number of registrations you enter in your cart. (You can reset the cart by entering 0 in the quantity field.)

340B in 2026: Market Shifts, Policy Battles, and
What They Mean for Stakeholders
ORDER

(You can reset the cart by entering 0 in the quantity field.)

Questions about corporate pricing? Please contact Marie Caldwell (mcaldwell@hmpglobal.com).

Purchasing access for multiple sites? We’ll contact you for your participant list. Or, download this spreadsheet and email your registrants’ information to dcisupport@hmpglobal.com.

Payment can be made with all major credit cards (Visa, MasterCard, American Express, and Discover). Prefer check or ACH? Click here to request an invoice.

IMPORTANT THINGS TO KNOW

  • Watch and listen via any modern browser via computer, tablet, or mobile. (No telephone access.)
  • Each registrant will receive an email with a link to watch the event. This link is unique to the registrant and can only be accessed once.
  • Every registrant will also receive a link to download Dr. Fein’s slides.
  • This event was part of The Drug Channels 2026 Video Webinar Series. If you already purchased access to the 2026 Drug Channels Video Webinar Series, then you already should have received an email from Zoom with a link to access the June 12, 2026, event.
  • Organizations that purchased corporate access for The Drug Channels 2026 Video Webinar Series will receive a custom, branded signup link so employees can easily register. We will automatically refund payments from anyone at a company with corporate access who purchases a single registration using their corporate email account.
  • Each registration for a DCI webinar is valid for a single device at a single physical location. Each device at a physical location requires its own registration. Attendees are not permitted to record, stream, share, or project a DCI webinar to other sites or locations. Purchasers who violate this limitation by recording, streaming, sharing, or projecting a DCI webinar to other sites, devices, or locations will be liable for the full cost of all locations that viewed the webinar. DCI reserves the right to prohibit purchasers who violate our terms from attending future DCI webinars.
  • Unfortunately, we are unable to offer refunds.